共查询到20条相似文献,搜索用时 109 毫秒
1.
《Journal of medical economics》2013,16(8):637-645
Abstract
Objective:
Conduct a cost effectiveness analysis for the Paliperidone palmitate Research In Demonstrating Effectiveness (PRIDE) trial. 相似文献2.
《Journal of medical economics》2013,16(9):691-703
Abstract
Objectives:
Quantify the costs and absenteeism associated with stages of the Hepatitis C virus (HCV). 相似文献3.
《Journal of medical economics》2013,16(6):410-419
Abstract
Objectives:
To project the cost-effectiveness of population-based echo screening to prevent rheumatic heart disease (RHD) consequences. 相似文献4.
《Journal of medical economics》2013,16(7):550-563
Abstract
Background:
Asthma and chronic obstructive pulmonary disease (COPD) are incurable diseases that impact quality-of-life. 相似文献5.
《Journal of medical economics》2013,16(6):457-465
Abstract
Objective:
To examine the direct and indirect costs of hemophilia care among persons with hemophilia A in the US. 相似文献6.
《Journal of medical economics》2013,16(8):646-653
Abstract
Objective:
To assess the effectiveness of managed care plans that limited access to infusion biologics via a step therapy policy. 相似文献7.
《Journal of medical economics》2013,16(9):704-710
Abstract
Objective:
To explore the effect of age and sex on cost of all-cause and multiple sclerosis (MS)-related inpatient facility encounters. 相似文献8.
《Journal of medical economics》2013,16(2):231-239
Abstract
Objective:
To compare hospitalizations and incidence of relapses among patients with schizophrenia initiating long-acting injectable (LAI) antipsychotics vs oral antipsychotics. 相似文献9.
《Journal of medical economics》2013,16(1):179-189
Abstract
Objective
This retrospective observational study describes treatment patterns and longitudinal health-related quality-of-life (HRQoL) among metastatic breast cancer patients with bone metastasis from nine community oncology clinics. 相似文献10.
《Journal of medical economics》2013,16(12):1020-1028
Abstract
Objective:
This study estimated the economic burden of obesity-related comorbidities (ORCs) in the US, at both the person and population levels. 相似文献11.
《Journal of medical economics》2013,16(6):420-432
Abstract
Objective:
To identify the direct and indirect costs of hypoglycemia in patients with Type 1 or Type 2 diabetes mellitus (DM) in the US setting. 相似文献12.
《Journal of medical economics》2013,16(2):202-212
Abstract
Objective:
To estimate the cost-effectiveness of ipilimumab (3?mg/kg) compared with best supportive care (BSC) in pre-treated advanced melanoma patients. 相似文献13.
《Journal of medical economics》2013,16(7):533-541
Abstract
Objective:
To study the economic burden of pregnancy in the US, common complications during pregnancy, and the incremental costs attributable to these complications. 相似文献14.
《Journal of medical economics》2013,16(2):298-306
Abstract
Objectives:
To assess factors associated with adherence to phosphodiesterase type 5 inhibitors (PDE5Is) in the management of pulmonary arterial hypertension (PAH). 相似文献15.
《Journal of medical economics》2013,16(5):349-356
Abstract
Objective:
To estimate direct medical costs for patients with tuberous sclerosis complex (TSC) and surgical resection of subependymal giant-cell astrocytoma (SEGA). 相似文献16.
《Journal of medical economics》2013,16(12):1041-1049
Abstract
Background:
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in the US, with an estimated prevalence of 2.7–6.1 million persons in 2010. 相似文献17.
《Journal of medical economics》2013,16(2):289-294
Abstract
Objective:
To analyze the achievements, issues and policy recommendations for implementing essential medicine system in China after a 3-year effort. 相似文献18.
《Journal of medical economics》2013,16(5):376-389
Abstract
Objective:
To estimate cost per patient-year in response during 2 years following biologic initiation among patients with rheumatoid arthritis (RA). 相似文献19.
《Journal of medical economics》2013,16(11):863-870
Abstract
Objective:
To assess the impact of initiation of asenapine on “real-world” levels of utilization and cost of healthcare services for the treatment of bipolar I disorder (BPD) in the US. 相似文献20.
《Journal of medical economics》2013,16(11):898-908
Abstract